Wearable dermal sensor

Information

  • Patent Grant
  • D988160
  • Patent Number
    D988,160
  • Date Filed
    Tuesday, March 16, 2021
    4 years ago
  • Date Issued
    Tuesday, June 6, 2023
    a year ago
  • Inventors
    • Morelock; David (Escondido, CA, US)
  • Original Assignees
  • Examiners
    • Davis; Antoine Duval
    Agents
    • Cooley LLP
  • US Classifications
    Field of Search
    • US
    • D10 78
    • D10 81
    • D24 108
    • D24 134
    • D24 186
    • D24 187
    • D24 216
    • CPC
    • A61M37/0015
    • A61M25/00
    • A61M2037/0023
    • A61M2037/0046
    • A61M2037/0053
    • A61M37/00
    • A61M2037/0007
    • A61M2037/0061
    • A61M2205/33
    • A61M2205/3303
    • A61M2210/04
    • A61M2230/20
    • A61B5/14503
    • A61B5/14514
    • A61B5/14532
    • A61B5/14546
    • A61B5/14865
    • A61B5/1495
    • A61B5/150022
    • A61B5/150282
    • A61B5/150427
    • A61B5/150969
    • A61B5/150984
    • A61B5/4839
    • A61B5/685
    • A61B2562/028
    • A61B2562/12
    • A61B2562/125
    • A61B2560/0242
    • A61B2560/0266
    • A61B2560/0271
    • A61B2560/04
    • A61B2560/0406
    • A61B2560/0412
    • A61B2562/16
    • A61B2562/162
    • A61B2562/164
    • A61B2562/166
    • A61B2562/168
    • A61B2562/0271
    • A61B2562/0272
    • A61B5/0008
    • C12Q1/006
    • G01N27/3271
    • Y10T29/49117
    • A61N1/326
    • A61N1/327
    • A61N1/0476
    • A61N1/0424
    • A61N1/044
    • A61N1/325
  • International Classifications
    • 2401
    • Term of Grant
      15Years
Abstract
Description


FIG. 1 is a top plan view of a first embodiment of a wearable dermal sensor;



FIG. 2 is a bottom plan view thereof;



FIG. 3 is a side elevation view thereof;



FIG. 4 is a side elevation view thereof;



FIG. 5 is a rear elevation view thereof;



FIG. 6 is a front elevation view thereof;



FIG. 7 is a top perspective view thereof;



FIG. 8 is a perspective view showing the wearable dermal sensor worn by a user;



FIG. 9 is a top perspective of a second embodiment of a wearable dermal sensor illustrating a first portion illuminated; and,



FIG. 10 is a top perspective of a third embodiment of a wearable dermal sensor illustrating a first portion illuminated and a second portion illuminated.


The broken lines show unclaimed environment only and form no part of the claimed design.


Claims
  • The ornamental design for a wearable dermal sensor, as shown and described.
US Referenced Citations (90)
Number Name Date Kind
4305401 Reissmueller et al. Dec 1981 A
4323996 Ganter Apr 1982 A
4407295 Steuer et al. Oct 1983 A
5131390 Sakaguchi Jul 1992 A
5279543 Glikfeld et al. Jan 1994 A
5286364 Yacynych et al. Feb 1994 A
5540828 Yacynych Jul 1996 A
5730714 Guy et al. Mar 1998 A
5766132 Yasukawa et al. Jun 1998 A
6036055 Mogadam et al. Mar 2000 A
6139718 Kurnik et al. Oct 2000 A
6269053 Kawata et al. Jul 2001 B1
6284126 Kurnik et al. Sep 2001 B1
6413396 Yang et al. Jul 2002 B1
6471903 Sherman et al. Oct 2002 B2
6603987 Whitson Aug 2003 B2
6814845 Wilson et al. Nov 2004 B2
6862466 Ackerman Mar 2005 B2
6908453 Fleming Jun 2005 B2
7097776 Raju Aug 2006 B2
7132054 Kravitz et al. Nov 2006 B1
7262068 Roy et al. Aug 2007 B2
7343188 Sohrab Mar 2008 B2
7344499 Prausnitz et al. Mar 2008 B1
7429333 Chiou et al. Sep 2008 B2
7456112 Lee Nov 2008 B2
7493232 Surina Feb 2009 B1
8022292 Arianpour et al. Sep 2011 B2
8088321 Ferguson et al. Jan 2012 B2
8094009 Allen et al. Jan 2012 B2
8125331 Allen et al. Feb 2012 B2
8130095 Allen et al. Mar 2012 B2
8284046 Allen et al. Oct 2012 B2
8574165 Marsh Nov 2013 B2
8798799 Deo et al. Aug 2014 B2
8909543 Tropper et al. Dec 2014 B2
D722697 Moon Feb 2015 S
D750786 Davies et al. Mar 2016 S
D757000 Lagomarsino et al. May 2016 S
9551698 Huys et al. Jan 2017 B2
9737247 Wang Aug 2017 B2
9743870 Wang Aug 2017 B2
D815289 Evers et al. Apr 2018 S
D816229 Frick et al. Apr 2018 S
9933387 McCanna et al. Apr 2018 B1
D820988 Pushpala Jun 2018 S
10092207 Windmiller Oct 2018 B1
10136846 Wang et al. Nov 2018 B2
D842996 Frick et al. Mar 2019 S
D845289 Chuang Apr 2019 S
10251565 Chan Apr 2019 B2
D867911 Alabdin Nov 2019 S
10492708 Windmiller Dec 2019 B1
D875254 Cooke Feb 2020 S
D882432 Yee Apr 2020 S
10765369 Antonio Sep 2020 B2
11045142 Windmiller et al. Jun 2021 B1
11207025 Trapero Martin Dec 2021 B1
20030225360 Eppstein Dec 2003 A1
20060015061 Kuo et al. Jan 2006 A1
20070170054 Wilsey Jul 2007 A2
20070213044 Steingart et al. Sep 2007 A1
20090088652 Tremblay Apr 2009 A1
20090143761 Cantor Jun 2009 A1
20090259118 Feldman et al. Oct 2009 A1
20100056873 Allen et al. Mar 2010 A1
20100286803 Tillotson Nov 2010 A1
20120323097 Chowdhury Dec 2012 A9
20130065257 Wang et al. Mar 2013 A1
20130144131 Wang et al. Jun 2013 A1
20140259652 Pushpala et al. Sep 2014 A1
20140275897 Pushpala Sep 2014 A1
20140336487 Wang et al. Nov 2014 A1
20150335272 Natale et al. Nov 2015 A1
20170055851 Al-Ali Mar 2017 A1
20180249937 Wiese et al. Sep 2018 A1
20190095602 Setlak et al. Mar 2019 A1
20190125223 Wang et al. May 2019 A1
20190167167 Mitchell et al. Jun 2019 A1
20190309433 Sattayasamitsathit et al. Oct 2019 A1
20200085341 Windmiller Mar 2020 A1
20200101286 Windmiller et al. Apr 2020 A1
20200214566 Allen et al. Jul 2020 A1
20200254240 Windmiller et al. Aug 2020 A1
20200297997 Windmiller et al. Sep 2020 A1
20210187286 Windmiller et al. Jun 2021 A1
20210393201 Morelock et al. Dec 2021 A1
20220031209 Windmiller et al. Feb 2022 A1
20220031244 Windmiller et al. Feb 2022 A1
20220175278 Windmiller et al. Jun 2022 A1
Foreign Referenced Citations (10)
Number Date Country
WO-2009034313 Mar 2009 WO
WO-2009034313 Mar 2009 WO
WO-2009064164 May 2009 WO
WO-2009064164 May 2009 WO
WO-2010120364 Oct 2010 WO
WO-2010120364 Oct 2010 WO
WO-2012020332 Feb 2012 WO
WO-2012020332 Feb 2012 WO
WO-2013058879 Apr 2013 WO
WO-2013058879 Apr 2013 WO
Non-Patent Literature Citations (26)
Entry
Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using Insulin or not,” 3 pages.
American Diabetes Association® Press Release (2020). “American Diabetes Association ©Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
Biolinq, Inc. (2019), The Intelligent Continuous Glucose Monitoring System, 5 total pages.
Cao, J et al. (2017), “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
Dexcom (2020). Analyst Day Presentation, 19 total pages.
Dexcom (2020). Analyst Day Presentation, 27 total pages.
Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021 ,” Diabetes Care 44(Supplement 1):S85-S99.
Fang, M. et al., (2021), “Trends in Diabetes Treatment and Control in U.S, Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
French, D.P. et al. (2008). “Original Article: Psychological Care Seif-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study),” J. Diab. Sci. Tech. 12:1211-1219.
Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring with Glycemic Control and Acute Metabolic Events Among Patients with Insulin-Treated Diabetes,” JAMA 325:2273-2284.
Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin a Randomized Clinical Trial,” JAMA 325:2262-2272.
McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography.” J. Biomed. Optics 9:274-281.
Non-Final Office Action dated Nov. 14, 2019. for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
Notice of Allowance dated Dec. 18, 2019, for U.S. Appl. No. 29/650,794, 63. filed Jun. 8, 2018, 7 pages.
Polonsky, W.H. et al. (2011), “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
Sheikh, Z. et al. (2015). “Macrophages. Foreign Body Giant Celis and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.